PC3 - 151 Toca 5: A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Patients Undergoing Planned Resection for Recurrent Glioblastoma (GBM) or Anaplastic Astrocytoma (AA) (NCT02414165)
Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/cjn.2016.379
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Cambridge University Press (CUP)